Humatin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Waylis Therapeutics Llc. The primary component is Paromomycin Sulfate.
Product ID | 80725-250_218563ce-a4f4-490b-99fe-eabc713bbdba |
NDC | 80725-250 |
Product Type | Human Prescription Drug |
Proprietary Name | Humatin |
Generic Name | Paromomycin Sulfate |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2021-04-08 |
Marketing Category | ANDA / |
Application Number | ANDA065173 |
Labeler Name | Waylis Therapeutics LLC |
Substance Name | PAROMOMYCIN SULFATE |
Active Ingredient Strength | 250 mg/1 |
Pharm Classes | Antiprotozoal [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2024-12-31 |
Marketing Start Date | 2021-04-08 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
69784-510 | Humatin | PAROMOMYCIN SULFATE |
80725-250 | Humatin | PAROMOMYCIN SULFATE |
23155-038 | Paromomycin Sulfate | Paromomycin Sulfate |
55695-022 | Paromomycin Sulfate | Paromomycin Sulfate |
57664-175 | Paromomycin Sulfate | Paromomycin Sulfate |
76413-147 | Paromomycin Sulfate | Paromomycin Sulfate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
HUMATIN 90135099 not registered Live/Pending |
Woodward Pharma Services LLC 2020-08-25 |
HUMATIN 72040694 0665305 Dead/Expired |
PARKE, DAVIS & COMPANY 1957-11-14 |